These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1522 related items for PubMed ID: 8541724

  • 1. Anti-tyrosinase antibodies participate in the immune response to vaccination with anti-idiotypic antibodies mimicking the high-molecular-weight melanoma-associated antigen.
    Baharav E, Merimsky O, Altomonte M, Shoenfeld Y, Pavlovic M, Maio M, Ferrone S, Fishman P.
    Melanoma Res; 1995 Oct; 5(5):337-43. PubMed ID: 8541724
    [Abstract] [Full Text] [Related]

  • 2. Idiotypic cascade in the human high molecular weight melanoma-associated antigen system: fine specificity and idiotypic profile of anti-anti-idiotypic monoclonal antibodies.
    Yang H, Chen ZJ, Kageshita T, Yamada M, Ferrone S.
    Eur J Immunol; 1993 Jul; 23(7):1671-7. PubMed ID: 7686858
    [Abstract] [Full Text] [Related]

  • 3. Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma.
    Mittelman A, Chen ZJ, Yang H, Wong GY, Ferrone S.
    Proc Natl Acad Sci U S A; 1992 Jan 15; 89(2):466-70. PubMed ID: 1731316
    [Abstract] [Full Text] [Related]

  • 4. Melanoma-associated hypopigmentation: where are the antibodies?
    Merimsky O, Shoenfeld Y, Baharav E, Altomonte M, Chaitchik S, Maio M, Ferrone S, Fishman P.
    Am J Clin Oncol; 1996 Dec 15; 19(6):613-8. PubMed ID: 8931683
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
    Mittelman A, Chen GZ, Wong GY, Liu C, Hirai S, Ferrone S.
    Clin Cancer Res; 1995 Jul 15; 1(7):705-13. PubMed ID: 9816036
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic MAb MK2-23. Immunohistochemical analysis of the reactivity of anti-anti-idiotypic MAb with surgically removed melanoma lesions.
    Kageshita T, Hirai S, Ono T, Ferrone S.
    Int J Cancer; 1995 Jan 27; 60(3):334-40. PubMed ID: 7829240
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the binding parameters to melanoma cells of antihuman high molecular weight-melanoma associated antigen (HMW-MAA) monoclonal antibodies (mAb) and syngeneic anti-anti-idiotypic (anti-anti-id) mAb.
    Chen ZJ, Ferrone S.
    Ann N Y Acad Sci; 1993 Aug 12; 690():398-401. PubMed ID: 8368768
    [No Abstract] [Full Text] [Related]

  • 10. Human high molecular weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody MK2-23. Characterization of the immunogenicity in syngeneic hosts.
    Chen ZJ, Yang H, Ferrone S.
    J Immunol; 1991 Aug 01; 147(3):1082-90. PubMed ID: 1861071
    [Abstract] [Full Text] [Related]

  • 11. Association between induction of anti high molecular weight-melanoma associated antigen (HMW-MAA) immunity with mouse antiidiotypic monoclonal antibody (MoAb) MK2-23 and prolongation of survival in patients with melanoma.
    Chen ZJ, Yang H, Liu CC, Mittelman A, Ferrone S.
    Pigment Cell Res; 1992 Aug 01; Suppl 2():113-22. PubMed ID: 1409413
    [No Abstract] [Full Text] [Related]

  • 12. Autoantibodies to tyrosinase: the bridge between melanoma and vitiligo.
    Fishman P, Merimski O, Baharav E, Shoenfeld Y.
    Cancer; 1997 Apr 15; 79(8):1461-4. PubMed ID: 9118024
    [Abstract] [Full Text] [Related]

  • 13. Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23.
    Mittelman A, Chen ZJ, Liu CC, Hirai S, Ferrone S.
    Cancer Res; 1994 Jan 15; 54(2):415-21. PubMed ID: 8275478
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Active specific immunotherapy of malignant melanoma with anti-idiotypic monoclonal antibodies.
    Ferrone S, Kageshita T, Hirai S.
    J Dermatol; 1993 Sep 15; 20(9):533-9. PubMed ID: 8227707
    [Abstract] [Full Text] [Related]

  • 17. Vaccination with a human high molecular weight melanoma-associated antigen mimotope induces a humoral response inhibiting melanoma cell growth in vitro.
    Wagner S, Hafner C, Allwardt D, Jasinska J, Ferrone S, Zielinski CC, Scheiner O, Wiedermann U, Pehamberger H, Breiteneder H.
    J Immunol; 2005 Jan 15; 174(2):976-82. PubMed ID: 15634921
    [Abstract] [Full Text] [Related]

  • 18. Antiantiidiotypic response and clinical course of the disease in patients with malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23.
    Mittelman A, Wang X, Matsumoto K, Ferrone S.
    Hybridoma; 1995 Apr 15; 14(2):175-81. PubMed ID: 7590776
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High-molecular-weight melanoma-associated antigen mimotope immunizations induce antibodies recognizing melanoma cells.
    Riemer AB, Hantusch B, Sponer B, Kraml G, Hafner C, Zielinski CC, Scheiner O, Pehamberger H, Jensen-Jarolim E.
    Cancer Immunol Immunother; 2005 Jul 15; 54(7):677-84. PubMed ID: 15565329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 77.